LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 195,900 Value ($000) $270 Avg Close — Range —
Q2 2024
Shares 192,609 Value ($000) $279 Avg Close — Range —
Q1 2024
Shares 33,000 Value ($000) $74 Avg Close — Range —
Q4 2023
Shares 33,000 Value ($000) $64 Avg Close — Range —
Q3 2023
Shares 33,000 Value ($000) $49 Avg Close — Range —